Cell Signaling Technology

Phospho-WNK1 (Thr60) Antibody

#4946 · $362

100

Citing papers

7.6k

Combined citations

Supplier page Find this product

Research areas

Cell death mechanisms and regulation10 Cancer-related Molecular Pathways7 RNA modifications and cancer7 PI3K/AKT/mTOR signaling in cancer6 NF-κB Signaling Pathways6 Immune Cell Function and Interaction5 Chronic Myeloid Leukemia Treatments5 Mitochondrial Function and Pathology5

Papers citing this product

1

Microbiome-Derived Tryptophan Metabolites and Their Aryl Hydrocarbon Receptor-Dependent Agonist and Antagonist Activities

Molecular Pharmacology·2014·337 cit.·DOI

2

Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer

Nature·2021·311 cit.·DOI

3

MicroRNA-155 Is Required for Effector CD8+ T Cell Responses to Virus Infection and Cancer

Immunity·2013·305 cit.·DOI

4

The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer

Nature Medicine·2021·253 cit.·DOI

5

Evidence for a TCR Affinity Threshold Delimiting Maximal CD8 T Cell Function

The Journal of Immunology·2010·223 cit.·DOI

6

Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy

Nature Communications·2020·206 cit.·DOI

7

Translation Initiation Factor eIF4G-1 Binds to eIF3 through the eIF3e Subunit

Journal of Biological Chemistry·2006·170 cit.·DOI

8

MLL-Rearranged Acute Lymphoblastic Leukemias Activate BCL-2 through H3K79 Methylation and Are Sensitive to the BCL-2-Specific Antagonist ABT-199

Cell Reports·2015·153 cit.·DOI

9

WNT7B Promotes Bone Formation in part through mTORC1

PLoS Genetics·2014·148 cit.·DOI

10

Position of eukaryotic initiation factor eIF1 on the 40S ribosomal subunit determined by directed hydroxyl radical probing

Genes & Development·2003·140 cit.·DOI

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.